The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family

International Journal of Oncology

Volumn 43, Issue 4, 2013, Pages 1244-1252

  MacCARTHY, Caitlin M ^a,b   Notario, Vicente ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

Cellular energy balance; ENTPD5 mt PCPH; Malignant transformation; Nucleoside triphosphate diphosphohydrolase activity; Oncoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENTPD5 PROTEIN; MT PCPH PROTEIN; ONCOPROTEIN; OXALIPLATIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; COLORECTAL CARCINOMA; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; IN VITRO STUDY; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; CARCINOGENESIS; CATALYSIS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; HUMANS; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS; PYROPHOSPHATASES;

EID: 84882379939     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2052     Document Type: Article

References (41)

1. Cairns RA, Harris IS and Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95, 2011.
2. Warburg O: On respiratory impairment in cancer cells. Science 124: 269-270, 1956.
3. Sattler UG, Hirschhaeuser F and Mueller-Klieser WF: Manipulation of glycolysis in malignant tumors: fantasy or therapy? Curr Med Chem 17: 96-108, 2010.
4. Hardt PD, Mazurek S, Toepler M, et al: Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer 91: 980-984, 2004.
5. Chan EC, Koh PK, Mal M, et al: Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8: 352-361, 2009.
6. Walenta S, Chau TV, Schroeder T, et al: Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists? J Cancer Res Clin Oncol 129: 321-326, 2003.
7. Robson SC, Sevigny J and Zimmermann H: The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2: 409-430, 2006.
8. Enjyoji K, Kotani K, Thukral C, et al: Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes 57: 2311-2320, 2008.
9. Read R, Hansen G, Kramer J, Finch R, Li L and Vogel P: Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest. Vet Pathol 46: 491-504, 2009.
10. Notario V, Castro R, Flessate DM, Doniger J and DiPaolo JA: Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Oncogene 5: 1425-1430, 1990.
11. Velasco JA, Avila MA and Notario V: The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress. Oncogene 18: 689-701, 1999.
12. Fang M, Shen Z, Huang S, et al: The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143: 711-724, 2010.
13. Recio JA, Páez JG, Sanders S, Kawakami T and Notario V: Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein. Cancer Res 62: 2690-2694, 2002.
14. Tirado OM, Mateo-Lozano S, Sanders S, Dettin LE and Notario V: The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation. Cancer Res 63: 6290-6298, 2003.
15. Villar J, Quadri HS, Song I, Tomita Y, Tirado OM and Notario V: PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase C-mediated Bcl-2 stabilization. Cancer Res 69: 102-110, 2009.
16. Rouzaut A, Recio JA and Notario V: Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines. Radiat Res 155: 181-187, 2001.
17. Blánquez MJ, Arenas MI, Conde I, Tirado OM, Paniagua R and Notario V: Deregulated expression of the PCPH proto-oncogene in human breast cancers. Int J Oncol 25: 821-830, 2004.
18. Villar J, Arenas MI, MacCarthy CM, Blánquez MJ, Tirado OM and Notario V: PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Res 67: 10859-10868, 2007.
19. Murphy-Piedmonte DM, Crawford PA and Kirley TL: Bacterial expression, folding, purification and characterization of soluble NTPDase5 (CD39L4) ecto-nucleotidase. Biochim Biophys Acta 1747: 251-259, 2005.
20. Recio JA, Páez JG, Maskeri B, Loveland M, Velasco JA and Notario V: Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1. Cancer Res 60: 1720-1728, 2000.
21. Le Guezennec X, Vermeulen M, Brinkman AB, et al: MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 26: 843-851, 2006.
22. Smith TM and Kirley TL: Site-directed mutagenesis of a human brain ecto-apyrase: evidence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily. Biochemistry 38: 321-328, 1999.
23. Wachstein M and Meisel E: Histochemistry of hepatic phosphatases of a physiologic pH; with special reference to the demonstration of bile canaliculi. Am J Clin Pathol 27: 13-23, 1957.
24. Abramoff MD, Magelhaes PJ and Ram SJ: Image processing with ImageJ. Biophotonics Int 11: 36-42, 2004.
25. Li Y, Park JS, Deng JH and Bai Y: Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J Bioenerg Biomembr 38: 283-291, 2006.
26. Mulero JJ, Yeung G, Nelken ST and Ford JE: CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates. J Biol Chem 274: 20064-20067, 1999.
27. Trombetta ES and Helenius A: Glycoprotein reglucosylation and nucleotide sugar utilization in the secretory pathway: identification of a nucleoside diphosphatase in the endoplasmic reticulum. EMBO J 18: 3282-3292, 1999.
28. Mulero JJ, Yeung G, Nelken ST, Bright JM, McGowan DW and Ford JE: Biochemical characterization of CD39L4. Biochemistry 39: 12924-12928, 2000.
29. Yang F, Hicks-Berger CA, Smith TM and Kirley TL: Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of residues in the apyrase conserved regions. Biochemistry 40: 3943-3950, 2001.
30. Smith TM, Lewis Carl SA and Kirley TL: Mutagenesis of two conserved tryptophan residues of the E-type ATPases: inactivation and conversion of an ecto-apyrase to an ecto-NTPase. Biochemistry 38: 5849-5857, 1999.
31. Miura P, Thompson J, Chakkalakal JV, Holcik M and Jasmin BJ: The utrophin A 5'-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers. J Biol Chem 280: 32997-33005, 2005.
32. Baykov AA, Evtushenko OA and Avaeva SM: A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 171: 266-270, 1988.
33. Zhang JT and Ling V: Involvement of cytoplasmic factors regulating the membrane orientation of P-glycoprotein sequences. Biochemistry 34: 9159-9165, 1995.
34. Massé K, Eason R, Bhamra S, Dale N and Jones EA: Comparative genomic and expression analysis of the conserved NTPDase gene family in Xenopus. Genomics 87: 366-381, 2006.
35. Recio JA, Zambrano N, de la Peña L, et al: cDNA isolation, expression, and chromosomal localization of the mouse pcph proto-oncogene. Mol Carcinog 26: 130-136, 1999.
36. Ivanenkov VV, Murphy-Piedmonte DM and Kirley TL: Bacterial expression, characterization, and disulfide bond determination of soluble human NTPDase6 (CD39L2) nucleotidase: implications for structure and function. Biochemistry 42: 11726-11735, 2003.
37. Zebisch M and Strater N: Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling. Proc Natl Acad Sci USA 105: 6882-6887, 2008.
38. Crawford PA, Gaddie KJ, Smith TM and Kirley TL: Characterization of an alternative splice variant of human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): a possible modulator of nucleotidase activity and purinergic signaling. Arch Biochem Biophys 457: 7-15, 2007.
39. Riewe D, Grosman L, Fernie AR, Wucke C and Geigenberger P: The potato-specific apyrase is apoplastically localized and has influence on gene expression, growth, and development. Plant Physiol 147: 1092-1109, 2008.
40. Regadera J, Blánquez MJ, González-Peramato P, et al: PCPH expression is an early event in the development of testicular germ cell tumors. Int J Oncol 28: 595-604, 2006.
41. Mikula M, Rubel T, Karczmarski J, Goryca K, Dadlez M and Ostrowski J: Integrating proteomic and transcriptomic high throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 11: 215-224, 2010.